Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts

Journal of Nutritional Biochemistry

Volumn 23, Issue 2, 2012, Pages 101-105

  Shaikh, Saame Raza ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Lipid rafts; N 3 PUFA

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; SIGNAL PEPTIDE;

BINDING AFFINITY; BIOCHEMICAL COMPOSITION; CARDIOVASCULAR RISK; DRUG MECHANISM; FOOD INTAKE; HUMAN; IN VITRO STUDY; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID RAFT; LIPID TRANSPORT; LIPIDOMICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REVIEW;

BIOPHYSICS; CHOLESTEROL; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS;

EID: 84855513677     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.07.001     Document Type: Review

References (46)

1. Roth E.M., Harris W.S. Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Rep 2010, 12:66-72.
2. Davidson M.H., Stein E.A., Bays H.E., Maki K.C., Doyle R.T., Shalwitz R.A., et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 2007, 29:1354-1367.
3. Galli C., Calder P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 2009, 55:123-139.
4. Harris W.S., Mozaffarian D., Lefevre M., Toner C.D., Colombo J., Cunnane S.C., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009, 139:804S-819S.
5. Fedor D., Kelley D.S. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opion Clin Nutr Metab Care 2009, 12:138-146.
6. Chapkin R.S., Kim W., Lupton J.R., McMurray D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leuk Essent Fatty Acid 2009, 81:187-191.
7. Shaikh S.R., Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr 2006, 84:1277-1289.
8. Pike L.J. Rafts defined: a report on the keystone symposium on lipid rafts and cell function. J Lipid Res 2006, 47:1597-1598.
9. Lingwood D., Simons K. Detergent resistance as a tool in membrane research. Nat Protocols 2007, 2:2159-2165.
10. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
11. Zheng Y.Z., Berg K.B., Foster L.J. Mitochondria do not contain lipid rafts, and lipid rafts do not contain mitochondrial proteins. J Lipid Res 2009, 50:988-998.
12. Yaqoob P., Shaikh S.R. The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care 2010, 13:156-166.
13. Stillwell W., Wassall S.R. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 2003, 126:1-27.
14. Wassall S.R., Stillwell W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim Biophys Acta 2009, 1788:24-32.
15. Wassall S.R., Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids 2008, 153:57-63.
16. Mihailescu M., Gawrisch K. The structure of polyunsaturated lipid bilayers important for rhodopsin function: a neutron diffraction study. Biophys J. 2006, 90:L04-L06.
17. Feller S.E., Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr Opin Struct Biol 2005, 15:416-422.
18. Eldho N.V., Feller S.E., Tristram-Nagle S., Polozov I.V., Gawrisch K. Polyunsaturated docosahexaenoic vs docosapentaenoic acid-differences in lipid matrix properties from the loss of one double bond. J Am Chem Soc 2003, 125:6409-6421.
19. Feller S.E., Gawrisch K., MacKerell A.D. Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J Am Chem Soc 2002, 124:318-326.
20. Mihailescu M., Soubias O., Worcester D., White S.H., Gawrisch K. Structure and dynamics of cholesterol-containing polyunsaturated lipid membranes studied by neutron diffraction and NMR. J Membr Biol 2011, 239:63-71.
21. Rosetti C., Pastorino C. Polyunsaturated and saturated phospholipids in mixed bilayers: a study from the molecular scale to the lateral lipid organization. J Phys Chem B 2011, 115:1002-1013.
22. Shaikh S.R., LoCascio D.S., Soni S.P., Wassall S.R., Stillwell W. Oleic- and docosahexaenoic acid-containing phosphatidylethanolamines differentially phase separate from sphingomyelin. Biochim Biophys Acta 2009, 1788:2421-2426.
23. Soni S.P., LoCascio D.S., Liu Y., Williams J.A., Bittman R., Stillwell W., et al. Docosahexaenoic acid enhances segregation of lipids between raft and nonraft domains: 2H-NMR study. Biophys J 2008, 95:203-214.
24. Shaikh S.R., Dumaual A.C., Castillo A., LoCascio D., Siddiqui R.A., Stillwell W., et al. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study. Biophys J 2004, 87:1752-1766.
25. Kucerka N., Marquardt D., Harroun T.A., Nieh M.P., Wassall S.R., de Jong D.H., et al. Cholesterol in bilayers with PUFA chains: doping with DMPC or POPC results in sterol reorientation and membrane-domain formation. Biochemistry 2010, 49:7485-7493.
26. Harroun T.A., Katsaras J., Wassall S.R. Cholesterol is found to reside in the center of a polyunsaturated lipid membrane. Biochemistry 2008, 47:7090-7096.
27. Stulnig T.M., Huber J., Leitinger N., Imre E.M., Angelisova P., Nowotny P., et al. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 2001, 276:37335-37340.
28. Ma D.W.L., Seo J., Davidson L.A., Callaway E.S., Fan Y., Lupton J.R., et al. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 2004, 18:1040-1042.
29. Fan Y., McMurray D.N., Ly L.H., Chapkin R.S. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr 2003, 133(6):1913-1920.
30. Altenburg J.D., Siddiqui R.A. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res 2009, 7:1013-1020.
31. Schley P.D., Brindley D.N., Field C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007, 137:548-553.
32. Duraisamy Y., Lambert D., O'Neill C.A., Padfield P.J. Differential incorporation of docosahexaenoic acid into distinct cholesterol-rich membrane raft domains. Biochem Biophys Res Comm 2007, 360:885-890.
33. Langelier B., Linard A., Bordat C., Lavialle M., Heberden C. Long chain-polyunsaturated fatty acids modulate membrane phospholipid composition and protein localization in lipid rafts of neural stem cell cultures. J Cell Biochem 2010, 110:1356-1364.
34. Rogers K.R., Kikawa K.D., Mouradian M., Hernandez K., McKinnon K.M., Ahwah S.M., et al. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 2010, 31:1523-1530.
35. Wong S.W., Kwon M., Choi A.M.K., Kim H., Nakahira K., Hwang D.H. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284(40):27384-27392.
36. Ye S., Tan L., Ma J., Shi Q., Li J. Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts. Prostaglandins Leukot Essent Fatty Acids 2010, 83:37-43.
37. Grimm M.O.W., Kuchenbecker J., Groesgen S., Burg V.K., Hundsdoerfer B., Rothhaar T.L., et al. Docosahexaenoic acid reduces amyloid β production via multiple, pleiotropic mechanism. J Biol Chem 2011, 286:14028-14039.
38. Shaikh S.R., Rockett B.D., Salameh M., Carraway K. Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells. J Nutr 2009, 139:1632-1639.
39. Fan Y.Y., Ly L.H., Barhoumi R., McMurray D.N., Chapkin R.S. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J Immunol 2004, 173:6151-6160.
40. Shaikh S.R., Cherezov V., Caffrey M., Soni S.P., LoCascio D., Stillwell W., et al. Molecular organization of cholesterol in unsaturated phosphatidylethanolamines: x-ray diffraction and solid state 2H NMR reveal differences with phosphatidylcholines. J Am Chem Soc 2006, 128:5375-5383.
41. Rockett B.D., Franklin A., Harris M., Teague H., Rockett A., Shaikh S.R. Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonrafts of EL4 and B cells. J Nutr 2011, 141:1041-1048.
42. Chapkin R.S., Wang N., Fan Y., Lupton J.R., Prior I.A. Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta 2008, 1778:466-471.
43. + T cells by affecting lipid raft formation. J Immunol 2008, 181:6236-6243.
44. Zech T., Ejsing C.S., Gaus K., de Wet B., Shevchenko A., Simons K., et al. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. EMBO J 2009, 28:466-476.
45. Kim W., Khan N.A., McMurray D.N., Prior I.A., Wang N., Chapkin R.S. Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog Lipid Res 2010, 49:250-261.
46. Bonilla D.L., Ly L.H., Fan Y.Y., Chapkin R.S., McMurray D.N. Incorporation of a dietary omega 3 fatty acid impairs murine macrophage responses to mycobacterium tuberculosis. PLoS One 2010, 5:e10878.